thalidomide has been researched along with Microglossia in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hegarty, A | 1 |
| Hodgson, T | 1 |
| Porter, S | 1 |
| Paulsen, K | 1 |
2 other studies available for thalidomide and Microglossia
| Article | Year |
|---|---|
Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.
Topics: Adolescent; Child; Crohn Disease; Female; Follow-Up Studies; Granuloma; Humans; Immunosuppressive Ag | 2003 |
Otological features in exomphalos-macro-glossia-gigantism syndrome (Wiedemann's syndrome).
Topics: Abnormalities, Drug-Induced; Adolescent; Audiometry; Deafness; Female; Gigantism; Hernia, Umbilical; | 1973 |